Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Moderna, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $122 Billion
- Q2 2025
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 416,020 shares of MRNA stock, worth $11.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
416,020
Previous 659,250
36.89%
Holding current value
$11.4 Million
Previous $18.7 Million
38.59%
% of portfolio
0.01%
Previous 0.02%
Shares
23 transactions
Others Institutions Holding MRNA
# of Institutions
860Shares Held
266MCall Options Held
28.5MPut Options Held
34.8M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$703 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$607 Million0.48% of portfolio
-
State Street Corp Boston, MA17.3MShares$475 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$244 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...